Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative and acid-fast bacteria
OwnerRaymond SCHUCHinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerRaymond SCHUCHinventor
Estimating the term…
Disclosed herein are pharmaceutical compositions comprising an effective amount of an isolated Chp peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs. 81-91 and 94-102, or a modified Chp peptide having about 80% sequence identity therewith, wherein the modified Chp peptide inhibits growth, reduces the population, or kills at least one species of Gram-negative or acid-fast bacteria; and a pharmaceutically acceptable carrier. Further disclosed herein are isolated Chp peptides, as well as vectors comprising a nucleic acid molecule that encode the Chp peptides and host cells comprising a vector. Also disclosed herein are methods of inhibiting the growth, reducing the population, or killing of at least one species of Gram-negative or acid-fast bacteria, methods of treating a bacterial infection in a subject, and methods for prevention, disruption, or treatment of a biofilm comprising a Gram-negative bacteria.
A pharmaceutical composition comprising:
(canceled)
(canceled)
(canceled)
-19. (canceled)
A method of inhibiting the growth, reducing the population, or killing of at least one species of Gram-negative bacteria, the method comprising contacting the bacteria with a composition comprising an effective amount of (i) a Chp peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs. 81-91 and 94-102 or active fragments thereof, or (ii) a modified Chp peptide having 80% sequence identity with the amino acid sequence of at least one of SEQ ID NOs. 81-91 and 94-102, said Chp peptide or modified Chp peptide having lytic activity for a period of time sufficient to inhibit said growth, reduce said population, or kill said at least one species of Gram-negative bacteria.
A method of inhibiting the growth, reducing the population, or killing of at least one species of acid-fast bacteria, the method comprising contacting the bacteria with a composition comprising an effective amount of (i) a Chp peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:
(canceled)
(canceled)
(canceled)
A method for prevention, disruption, or eradication of a biofilm comprising at least one species of Gram-negative bacteria, the method comprising contacting a biofilm with a pharmaceutical composition comprising (i) an isolated Chp peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs. 81-91 and 94-102 or active fragment thereof, or (ii) a modified Chp peptide having 80% sequence identity with the amino acid sequence of at least one of SEQ ID NOs. 81-91 and 94-102, wherein the modified Chp peptide inhibits the growth, reduces the population, or kills at least one species of Gram-negative bacteria, and wherein the biofilm is effectively prevented, dispersed, or eradicated.
Dependencies are inferred from the claim text.